We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Inherited Epilepsy Due to Defective Sodium Channels

By Biotechdaily staff writers
Posted on 25 Jun 2002
Researchers investigating the molecular basis for epilepsy have found that mutant sodium channels are a likely cause. More...
The research was reported in the June 13, 2002, issue of Neuron.

Inherited epilepsy syndromes account for about 5% of all epilepsies. Many of the identified genetic mutations associated with inherited epilepsies are in genes that encode ion channels that regulate the flow of electric current, in the form of charged molecules, into or out of the cell.

The current study focused on three sodium channel mutations that are associated with a syndrome called generalized epilepsy with febrile seizures plus (GEFS+). Researchers from Vanderbilt University Medical Center (Nashville, TN, USA) isolated the human SCN1A sodium channel gene from individuals with this type of epilepsy and introduced the gene, with or without epilepsy-associated mutations, into normal human cells in the laboratory.

"We were able to reconstitute sodium channel function in the laboratory in a way that is very similar to the natural neuronal cell in a human being,” explained Dr. Alfred L. George.

With this system, the investigators examined sodium channels bearing one of three epilepsy-associated mutations. In each case, they found that the functional properties of the mutant channels were very similar to those of a normal channel, but that the mutant sodium channels failed to become completely inactivated. Complete inactivation protects the cell from repetitive electrical discharge by closing the ion channel.

"In the case of the mutant sodium channels, the inactivation process is defective.” Dr. George said. "What this does, is allow sodium to continue to enter the cell, leading to a state of hyperexcitability that makes repetitive firing--a hallmark of seizure activity--more likely. This minor defect is sufficient to render the cell susceptible to repeat firing. It is a plausible mechanism for epilepsy at the cellular and molecular level.”

Now that the physiologic event has been identified, drugs can be designed and tested to find those best at suppressing the abnormal non-inactivating current while leaving the normal current alone.



Related Links:
Vanderbilt University Medical Center

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Silver Member
Connectivity Solution
EKF Link
Portable POCT Blood Gas Analyzer
BD100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Dr. Olivia Belbin, head of the Molecular Neurodegeneration Group at IR Sant Pau and study corresponding author, with Alba Cervantes (right), first author and IR Sant Pau researcher (Photo courtesy of IR Sant Pau)

Blood Biomarker Detects Alzheimer’s Changes Decades Before Symptoms in Down Syndrome

Alzheimer’s disease can begin altering the brain long before clinical symptoms appear, creating a challenge for early-stage detection and research. People with Down syndrome face a particularly high age-related... Read more

Molecular Diagnostics

view channel
Photo courtesy of National Human Genome Research Institute

Genomic Screening Expands Detection of Treatable Conditions in Newborns

Conventional newborn screening can miss conditions that lack biochemical biomarkers or present atypically. Initial hearing screens may also fail to detect hearing loss that is later identified through... Read more

Microbiology

view channel
Image: Invasive aspergillosis (IA) is a potentially life-threatening infection caused by Aspergillus mold that primarily affects people with severely weakened immune systems. (Image Credit: Adobe Stock)

Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis

Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: NMPA approvals for Quanterix HD-X and SR-X instruments and four neurology biomarker assays expand access to ultrasensitive blood-based testing in China (Photo courtesy of Quanterix Corporation)

Regulatory Milestone Expands Access to Blood-Based Neurology Biomarker Testing in China

Quanterix Corporation (Billerica, MA, USA) and Innovita Biological Technology Co., Ltd. (Beijing, China) announced regulatory approvals that expand access to Quanterix SIMOA technology and neurology biomarker... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.